SGLT2i treatment at the beginning of real time exposure in a HFrEF population

被引：0
|
作者：
Vintila, V. [1 ]
Ciocanel, A. [2 ]
Stamate, E. [2 ]
Vintila, A. M. [3 ]
Vinereanu, D. [1 ]
机构：
[1] Univ Med & Pharm Carol Davila, Univ & Emergency Hosp Bucharest, Cardiol Dept, Bucharest, Romania
[2] Univ Emergency Hosp Bucharest, Cardiol Dept, Bucharest, Romania
[3] Univ Med & Pharm Carol Davila, Internal Med Dept, Coltea Clin Hosp, Bucharest, Romania
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2024年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：251 / 251
页数：1
相关论文
共 50 条
  • [31] Potential adverse effects of SGLT2i in horses
    McGorum, Bruce C.
    Keen, John A.
    McCullagh, Sophie
    Marr, Celia M.
    MacKenzie, Catriona
    Carslake, Harry
    Menzies-Gow, Nicola
    Dunkel, Bettina
    Hewetson, Mike
    Reed, Jennifer
    Knowles, Edd
    VETERINARY RECORD, 2024, 195 (06) : 253 - 254
  • [32] Real-Time Use of SGLT2i Verified in Pre-dialysis: The RSVP Cross-sectional Study
    Wisbaum, Aylon
    Gaudreau, Sandrine
    Cloutier, Isabelle
    Robert, Pascale
    Kolment, Regina
    Beauchesne, Marie-France
    Couture, Jodianne
    ANNALS OF PHARMACOTHERAPY, 2025, 59 (01) : 13 - 22
  • [33] New data on NOVEL ORAL ANTICOAGULANT, SGLT2i, lipid treatment and genetics
    Agewall, Stefan
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2024, 10 (02) : 83 - 84
  • [34] Personalized management of diabetes for the titration of insulin during initiation of SGLT2i treatment
    Balazki, Pavel
    Schaller, Stephan
    Eissing, Thomas
    Lehr, Thorsten
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 : S93 - S94
  • [35] Effect on Renal Function of SGLT2i Treatment in Hospitalized Patients with Type 2 Diabetes-A Real-World Study
    Bashkin, Amir
    Kruzel-Davila, Etty
    Tzfoni, Itai
    DIABETES, 2023, 72
  • [36] SAFETY OF SGLT2 INHIBITORS (SGLT2I) IN PEOPLE OVER 75 YEARS
    Marques Vidas, Maria
    Domenech, Ester
    Martin Testillano, Lucia
    Maroto, Alba
    Lopez, Paula
    Portoles, Jose' M.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I104 - I104
  • [37] Comparing treatment strategies for heart failure: a real-world analysis of adding ARNI or SGLT2i to older GDMT
    Amornritvanich, P.
    Numthavaj, P.
    Anothaisintawee, T.
    Tansawet, A.
    Thakkinstian, A.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [38] Early Experience with SGLT2i in Systemic Lupus Erythematosus
    Petri, Michelle
    Goldman, Daniel
    Fava, Andrea
    Magder, Larry
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2941 - 2943
  • [39] SGLT2i: beyond the glucose-lowering effect
    Ni, Lihua
    Yuan, Cheng
    Chen, Guopeng
    Zhang, Changjiang
    Wu, Xiaoyan
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
  • [40] ARNI and SGLT2i: a promising association to be used with caution
    Herbst, Andrea
    Orso, Francesco
    Migliorini, Marta
    Virciglio, Simona
    Tognelli, Silvia
    Camartini, Viola
    Pratesi, Alessandra
    Fattirolli, Francesco
    Marchionni, Niccolo
    Ungar, Andrea
    Baldasseroni, Samuele
    JOURNAL OF GERIATRIC CARDIOLOGY, 2020, 17 (11) : 728 - 732
12345